Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allegrini

Showing results (671-680 of 719) with videos related to

Pageof 72
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 18, 2016
Efficacy of FOLFOXIRI plus bevacizumab in liver-limited metastatic colorectal cancer: A pooled analysis of clinical studies by Gruppo Oncologico del Nord OvestChiara Cremolini, Mariaelena Casagrande, Fotios Loupakis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 12, 2018
Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONOE Dell'Aquila, C Cremolini, T Zeppola, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2022
FOLFOXIRI and bevacizumab in patients with early-onset metastatic colorectal cancer. A pooled analysis of TRIBE and TRIBE2 studiesCarlotta Antoniotti, Marco M Germani, Daniele Rossini, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 20, 2020
The importance of patients' case-mix for the correct interpretation of the hospital fatality rate in COVID-19 diseaseAntonella d'Arminio Monforte, Alessandro Tavelli, Francesca Bai, et al.
Oncotarget|March 1, 2018
<i>DPYD</i> and <i>UGT1A1</i> genotyping to predict adverse events during first-line FOLFIRI or FOLFOXIRI plus bevacizumab in metastatic colorectal cancerChiara Cremolini, Marzia Del Re, Carlotta Antoniotti, et al.
Journal of Geophysical Research. Space Physics|July 18, 2022
A Preliminary Study of Magnetosphere-Ionosphere-Thermosphere Coupling at Jupiter: Juno Multi-Instrument Measurements and Modeling ToolsYuxian Wang, Michel Blanc, Corentin Louis, et al.
Cell Reports. Medicine|May 8, 2025
RSPO1, a potent inducer of pancreatic β cell neogenesisSerena Silvano, Tiziana Napolitano, Magali Plaisant, et al.
Clinical and Experimental Medicine|August 27, 2023
Non-pegylated liposomal doxorubicin in older adjuvant early breast cancer patients: cardiac safety analysis and final results of the COLTONE studyLuigi Coltelli, Chiara Finale, Gianna Musettini, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 11, 2021
Female gender is associated with long COVID syndrome: a prospective cohort studyFrancesca Bai, Daniele Tomasoni, Camilla Falcinella, et al.
Vaccines|April 23, 2022
Real World Estimate of Vaccination Protection in Individuals Hospitalized for COVID-19Antonella d'Arminio Monforte, Alessandro Tavelli, Sara De Benedittis, et al.
Pageof 72

Showing results (671-680 of 719) with videos related to

Sort By:
Pageof 72
European Journal of Cancer (Oxford, England : 1990)|December 18, 2016
Efficacy of FOLFOXIRI plus bevacizumab in liver-limited metastatic colorectal cancer: A pooled analysis of clinical studies by Gruppo Oncologico del Nord OvestChiara Cremolini, Mariaelena Casagrande, Fotios Loupakis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 12, 2018
Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONOE Dell'Aquila, C Cremolini, T Zeppola, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2022
FOLFOXIRI and bevacizumab in patients with early-onset metastatic colorectal cancer. A pooled analysis of TRIBE and TRIBE2 studiesCarlotta Antoniotti, Marco M Germani, Daniele Rossini, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 20, 2020
The importance of patients' case-mix for the correct interpretation of the hospital fatality rate in COVID-19 diseaseAntonella d'Arminio Monforte, Alessandro Tavelli, Francesca Bai, et al.
Oncotarget|March 1, 2018
<i>DPYD</i> and <i>UGT1A1</i> genotyping to predict adverse events during first-line FOLFIRI or FOLFOXIRI plus bevacizumab in metastatic colorectal cancerChiara Cremolini, Marzia Del Re, Carlotta Antoniotti, et al.
Journal of Geophysical Research. Space Physics|July 18, 2022
A Preliminary Study of Magnetosphere-Ionosphere-Thermosphere Coupling at Jupiter: Juno Multi-Instrument Measurements and Modeling ToolsYuxian Wang, Michel Blanc, Corentin Louis, et al.
Cell Reports. Medicine|May 8, 2025
RSPO1, a potent inducer of pancreatic β cell neogenesisSerena Silvano, Tiziana Napolitano, Magali Plaisant, et al.
Clinical and Experimental Medicine|August 27, 2023
Non-pegylated liposomal doxorubicin in older adjuvant early breast cancer patients: cardiac safety analysis and final results of the COLTONE studyLuigi Coltelli, Chiara Finale, Gianna Musettini, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 11, 2021
Female gender is associated with long COVID syndrome: a prospective cohort studyFrancesca Bai, Daniele Tomasoni, Camilla Falcinella, et al.
Vaccines|April 23, 2022
Real World Estimate of Vaccination Protection in Individuals Hospitalized for COVID-19Antonella d'Arminio Monforte, Alessandro Tavelli, Sara De Benedittis, et al.
Pageof 72